Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Return on Capital Employed: 2022-2025

Historic Return on Capital Employed for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Sep 2025 value amounting to -1.42%.

  • Orchestra BioMed Holdings' Return on Capital Employed fell 37.00% to -1.42% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.42%, marking a year-over-year decrease of 37.00%. This contributed to the annual value of -0.93% for FY2024, which is 31.00% down from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Return on Capital Employed stood at -1.42% for Q3 2025, which was up 32.72% from -2.10% recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Return on Capital Employed ranged from a high of -0.37% in Q2 2023 and a low of -2.10% during Q2 2025.
  • Its 3-year average for Return on Capital Employed is -0.94%, with a median of -0.93% in 2024.
  • Data for Orchestra BioMed Holdings' Return on Capital Employed shows a maximum YoY plummeted of 118bps (in 2025) over the last 5 years.
  • Over the past 4 years, Orchestra BioMed Holdings' Return on Capital Employed (Quarterly) stood at -0.51% in 2022, then declined by 3bps to -0.54% in 2023, then plummeted by 54bps to -1.08% in 2024, then tumbled by 37bps to -1.42% in 2025.
  • Its Return on Capital Employed stands at -1.42% for Q3 2025, versus -2.10% for Q2 2025 and -1.32% for Q1 2025.